Devraj Srinivasan
Impact in
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
Papers in
-
- Head and Neck Cancer Studies 4
-
- Dysphagia Assessment and Management 2
- Co-authors
- Kirsten Stewart (4 shared papers)Iain James Nixon (3 shared papers)Mark W. J. Strachan (3 shared papers)Lucy R. Wall (3 shared papers)Martin Zeidler (1 shared paper)Tessa Fulton‐Lieuw (1 shared paper)Bernie Foran (1 shared paper)Max Robinson (1 shared paper)
- Journals
- The Lancet (2 papers)European Thyroid Journal (1 paper)Trials (1 paper)European Journal of Surgical Oncology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United KingdomNetherlands
In The Last Decade
Devraj Srinivasan
10 papers receiving 2.2k citations
Devraj Srinivasan's Hit Papers
Peers
Comparison fields: 5 of 83
- Otorhinolaryngology 1.1k
- Oncology 909
- Pulmonary and Respiratory Medicine 429
- Immunology 226
- Cancer Research 137
Countries citing papers authored by Devraj Srinivasan
This map shows the geographic impact of Devraj Srinivasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devraj Srinivasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devraj Srinivasan more than expected).
Fields of papers citing papers by Devraj Srinivasan
This network shows the impact of papers produced by Devraj Srinivasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devraj Srinivasan. The network helps show where Devraj Srinivasan may publish in the future.
Co-authors
The 24 scholars most cited alongside Devraj Srinivasan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study Hit paper breakdown → | 2018 | 1366 |
| 2 | Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial Hit paper breakdown → | 2018 | 767 |
| 3 | 2023 | 63 | |
| 4 | 2019 | 34 | |
| 5 | 2023 | 12 | |
| 6 | 2024 | 6 | |
| 7 | 2018 | 4 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 2 |
About Devraj Srinivasan
Devraj Srinivasan is a scholar working on Otorhinolaryngology, Speech and Hearing, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Rheumatology, having authored 10 papers that have together received 2.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (4 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Dysphagia Assessment and Management (2 papers), Glycogen Storage Diseases and Myoclonus (1 paper), Salivary Gland Tumors Diagnosis and Treatment (1 paper), Lung Cancer Research Studies (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Autoimmune Neurological Disorders and Treatments (1 paper). The work is most often cited by research in Otorhinolaryngology (1.1k citations), Oncology (909 citations), Pulmonary and Respiratory Medicine (429 citations), Immunology (226 citations) and Cancer Research (137 citations). Devraj Srinivasan has collaborated with scholars based in United Kingdom and Netherlands. Frequent co-authors include Kirsten Stewart, Iain James Nixon, Mark W. J. Strachan, Lucy R. Wall, Martin Zeidler, Tessa Fulton‐Lieuw, Bernie Foran, Max Robinson, R. Molerón and Matthew J. Dalby. Their work appears in journals such as The Lancet, European Thyroid Journal, Trials, European Journal of Surgical Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.